Ketamine as a new treatment for depression: a review of its efficacy and adverse effects.
about
Role of ketamine in acute postoperative pain management: a narrative reviewPreemptive analgesia effects of ketamine in patients undergoing surgery. A meta-analysisKetamine as a potential treatment for suicidal ideation: a systematic review of the literatureIs off-label repeat prescription of ketamine as a rapid antidepressant safe? Controversies, ethical concerns, and legal implications.Analysis of print news media framing of ketamine treatment in the United States and Canada from 2000 to 2015.Effects of Low-Dose and Very Low-Dose Ketamine among Patients with Major Depression: a Systematic Review and Meta-Analysis.Intravenous Morphine vs Intravenous Ketofol for Treating Renal Colic; a Randomized Controlled TrialKetamine for depression relapse prevention following electroconvulsive therapy: protocol for a randomised pilot trial (the KEEP-WELL trial).Inflammation: a mechanism of depression?Managing inadequate antidepressant response in depressive illness.New use for an old drug: oral ketamine for treatment-resistant depression.Circuit dysregulation and circuit-based treatments in posttraumatic stress disorder.The use of ketamine in ECT anaesthesia: A systematic review and critical commentary on efficacy, cognitive, safety and seizure outcomes.Shortened Spadin Analogs Display Better TREK-1 Inhibition, In Vivo Stability and Antidepressant Activity.Pilot dose-response trial of i.v. ketamine in treatment-resistant depression.Mental health policy and the burden of psychosis.The effects of low-dose ketamine on the prefrontal cortex and amygdala in treatment-resistant depression: A randomized controlled study.Should ketamine be used for the clinical treatment of depression?Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study.Long-Term Ketamine Self-Injections in Major Depressive Disorder: Focus on Tolerance in Ketamine's Antidepressant Response and the Development of Ketamine Addiction.Oral ketamine augmentation for chronic suicidality in treatment-resistant depression.
P2860
Q26779981-98E27E51-E390-410D-9DE6-5DC8490FC623Q26853342-1A5C7A52-6B03-44FA-83B9-7E371D747B05Q34043478-D2E46E0E-2A99-4589-9771-A8D1EC4761D2Q35894579-1069DC75-41D0-4324-B1E5-AC0E2D569320Q36296872-5702F218-E71F-4047-9166-17344289F44EQ36852411-67EFE132-14E4-45C9-AE3D-DCFE00EC8F15Q37224483-07A3D121-47C9-49FB-A69D-6182B1F24D4FQ37498103-15100EAF-6AA4-44A2-8630-443AB4665380Q38212575-547F513E-5751-4847-A71F-C7C421EE4BF1Q38574699-499A3A01-5824-4C11-9540-3794BD7A3D73Q38917733-F1E6D774-3809-4AFB-BDD1-3CBC36959564Q39009019-BD321BDE-91B1-4321-BBDD-704C2BD8454DQ39021973-2002C8B2-6717-45F0-B465-FA45E9B61830Q41684438-13F6DB05-1DB1-4A93-A907-A5FA070ABBBEQ44499360-2CEA2227-94D0-44E0-A1BD-7A133AA4EA43Q44547077-E73C4048-7BD9-4D88-9D50-1894D4768B71Q47597246-142A8BE1-9FC3-423C-B3C1-1BD0FC3FB712Q47632993-F3969C0B-10F0-4A08-94B8-B12AD524216CQ47637552-558D43C8-C860-4BAF-B5C9-AD6F54CB6EACQ47658882-CB808E35-2531-4035-A782-89C89F055B84Q47921243-175F9A84-B936-4788-9053-A08F77AC8F5C
P2860
Ketamine as a new treatment for depression: a review of its efficacy and adverse effects.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Ketamine as a new treatment for depression: a review of its efficacy and adverse effects.
@en
type
label
Ketamine as a new treatment for depression: a review of its efficacy and adverse effects.
@en
prefLabel
Ketamine as a new treatment for depression: a review of its efficacy and adverse effects.
@en
P2093
P2860
P356
P1476
Ketamine as a new treatment for depression: a review of its efficacy and adverse effects.
@en
P2093
Andrew Somogyi
Natalie Katalinic
Rosalyn Lai
P2860
P304
P356
10.1177/0004867413486842
P577
2013-05-09T00:00:00Z